Page last updated: 2024-09-03

umifenovir and Esophageal Squamous Cell Carcinoma

umifenovir has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dong, Z; Jiang, Y; Kim, MO; Laster, KV; Li, X; Liu, K; Lu, X; Wang, D; Wei, Y; Yang, N; Yu, Y; Yuan, B; Zhao, L1

Other Studies

1 other study(ies) available for umifenovir and Esophageal Squamous Cell Carcinoma

ArticleYear
Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase.
    eLife, 2022, 09-09, Volume: 11

    Topics: Apoptosis; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Indoles; Protein Kinases; Sulfides

2022